Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis

被引：0
|
作者：
Cauley, Jane A. [1 ]
Black, Dennis M. [1 ]
Levine, Bruce J. [1 ]
Eriksen, Erik F. [1 ]
Hu, Huilin [1 ]
Cummings, Steven R. [1 ]
机构：
[1] Univ Pittsburgh, Pittsburgh, PA USA
来源：
OBSTETRICS AND GYNECOLOGY | 2007年 / 109卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：112S / 113S
页数：2
相关论文
共 50 条
  • [21] EFFICACY OF ONCE-YEARLY ZOLEDRONIC ACID 5 MG IN MEN WITH OSTEOPOROSIS WITH DIFFERENT LEVELS OF SERUM TOTAL TESTOSTERONE
    Boonen, Steven
    Reginster, Jean-Yves
    Kaufman, Jean-Marc
    Lippuner, Kurt
    Zanchetta, Jose
    Langdahl, Bente
    Rizzoli, Rene
    Dimai, Hans Peter
    Eriksen, Erik
    Brixen, Kim
    Antunez, Oscar
    Su, Guoqin
    Hruska, Josef
    Vanderschueren, Dirk
    Orwoll, Eric
    OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S79 - S80
  • [22] Effect of once-yearly zoledronic acid 5 mg on 'Super Six' non-vertebral fractures
    Black, D. M.
    Eastell, R.
    Cosman, F.
    Man, Z.
    Bucci-Rechtweg, C.
    Mesenbrink, P.
    BONE, 2009, 44 (02) : S429 - S429
  • [23] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
    Delmas, P. D.
    Bauer, D.
    Black, D.
    Boonen, S. R.
    Cosman, F.
    Eastell, R.
    CALCIFIED TISSUE INTERNATIONAL, 2007, 80 : S29 - S29
  • [24] ANTIFRACTURE EFFICACY AND SAFETY OF ONCE-YEARLY ZOLEDRONIC ACID 5 MG IN MEN WITH OSTEOPOROSIS: A PROSPECTIVE, RANDOMIZED, CONTROLLED TRIAL
    Boonen, Steven
    Su, Guoqin
    Incera, Elodie
    Orwoll, Eric
    Kaufman, Jean-Marc
    Reginster, Jean-Yves
    Rizzoli, Rene
    Lippuner, Kurt
    Vanderschueren, Dirk
    Bucci-Rechtweg, Christina
    Antunez, Oscar
    Papanastasiou, Phil
    OSTEOPOROSIS INTERNATIONAL, 2011, 22 : 112 - 112
  • [25] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: data from HORIZON-PFT
    Delmas, P. D.
    Bauer, D.
    Black, D.
    Boonen, S.
    Cosman, F.
    Eastell, R.
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S130 - S131
  • [26] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-pft
    Delmas, P.
    Bauer, D.
    Black, D.
    Boonen, S.
    Cosman, F.
    Eriksen, E. F.
    Mesenbrink, R.
    Eastell, R.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 523 - 523
  • [27] Effect of once-yearly infusion of zoledronic acid 5 mg on biochemical markers of bone turnover: Data from horizon-PFT
    Delmas, Pierre
    Bauer, Douglas
    Black, Dennis
    Boonen, Steven R.
    Cosman, Felicia
    Eastell, Richard
    OSTEOPOROSIS INTERNATIONAL, 2007, 18 : S214 - S215
  • [28] The Addition of Once-Yearly Zoledronic Acid 5mg to Non-Bisphosphonate Treatment for Osteoporosis Reduced Fractures in Postmenopausal Women: The Horizon-Pivotal Fracture Trial
    Reid, David
    Delmas, Pierre
    Eastell, Richard
    Boonen, Steven
    Cummings, Steven
    Palermo, Lisa
    Cauley, Jane
    Recknor, Chris
    Cosman, Felicia
    Mesenbrink, Peter
    Krieginan, Andrey
    Eriksen, Erik
    Black, Dennis
    MENOPAUSE-THE JOURNAL OF THE NORTH AMERICAN MENOPAUSE SOCIETY, 2008, 15 (06): : 1204 - 1205
  • [29] HORIZON: Yearly infusion of zoledronic acid reduces risk of fracture in postmenopausal women with osteoporosis
    不详
    FORMULARY, 2007, 42 (08) : 488 - 489
  • [30] The effects of zoledronic acid 5 mg once-yearly on bone remodeling and structure in osteoporotic women are consistent across age
    Recker, R. R.
    Delmas, P.
    Reid, I.
    Boonen, S.
    Halse, J.
    Garcia, P.
    Supronik, J.
    Lewiecki, M.
    Ochoa, L.
    Miller, P.
    Hartl, F.
    Gasse, J. A.
    Mesenbrink, P.
    Hu, H.
    Eriksen, E.
    JOURNAL OF BONE AND MINERAL RESEARCH, 2007, 22 : S129 - S129
12345